Jpn. J. Pharmacol. 85 (3), 282-290 (2001)


TRK-820, a Selective k-Opioid Agonist, Produces Potent Antinociception in Cynomolgus Monkeys

Takashi Endoh1,*, Atsushi Tajima1, Naoki Izumimoto1, Tomohiko Suzuki1, Akiyoshi Saitoh1, Tsutomu Suzuki2, Minoru Narita2,4, Junzo Kamei3, Leon F. Tseng4, Hirokazu Mizoguchi4 and Hiroshi Nagase1

1Pharmaceutical Laboratories, Toray Industries Inc., 1111 Tebiro, Kamakura, Kanagawa 248-8555, Japan
2Department of Toxicology and 3Department of Pathophysiology and Therapeutics, Faculty of Pharmaceutical Science, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo 142-8501, Japan
4Department of Anesthesiology, Medical College of Wisconsin, Milwaukee, WI 53226, USA
*Corresponding author. Present address for correspondence: Toxicology Laboratory, Pharmaceutical Laboratories, Toray Industries Inc., 3-1-2 Sonoyama, Otsu, Shiga 520-0842, Japan
FAX: +81-77-533-8692, E-mail: takashi_endo@nts.toray.co.jp


Abstract: TRK-820 ((-)-17-cyclopropylmethyl-3,14b-dihydroxy-4,5a-epoxy-6b-[N-methyl-trans-3-(3-furyl)acrylamide]morphinan hydrochloride) has been shown to be a potent opioid k-receptor agonist with pharmacological properties different from those produced by k1-opioid receptor agonists in rodents. To ascertain whether or not these properties of TRK-820 would be extended to primates, the antinociceptive effect of TRK-820 was evaluated in cynomolgus monkeys by the hot-water tail-withdrawal procedure. TRK-820 given intramuscularly (i.m.) produced a potent antinociceptive effect that was 295- and 495-fold more potent than morphine with the 50íC and 55íC hot-water tests, respectively, and 40-fold more potent than U-50,488H and 1,000-fold more potent than pentazocine in the 50íC hot-water test. The duration of antinociceptive effects of TRK-820 treatment (0.01 and 0.03 mg/kg, i.m.) lasted more than 6 h, which was much longer than those of U-50,488H. The antinociception produced by the higher dose (0.03 mg/kg, i.m.) of TRK-820 was not inhibited by nor-binaltorphimine (3.2 and 10 mg/kg, s.c.) or by naloxone (0.1 mg/kg, s.c.), although the antinociception induced by a lower dose of TRK-820 (0.01 mg/kg, i.m.) was inhibited by nor-binaltorphimine (10 mg/kg, s.c.). The same doses of nor-binaltorphimine and naloxone effectively inhibited the antinociception induced by the higher doses of U-50,488H (1.0 mg/kg, i.m.) and morphine (10 mg/kg, i.m.), respectively. These results indicate that the antinociception induced by TRK-820 is less sensitive to nor-binaltorphimine and suggest that it is mediated by the stimulation of a subtype of k-opioid receptor different from the k1-opioid receptor in cynomolgus monkeys.

Keywords: k-Opioid agonist, Antinociceptive effect, TRK-820, Cynomolgus monkey, k-Opioid receptor subtype

[Back to TOC]